Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Various thoughts

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Nov 30, 2023 3:46pm

256 Views

Post# 35761959

RE:Various thoughts

Where, beyond your own personal opinion are you getting the 18 month requirement from the FDA? It's a change from the initial trial protocol which would be material and should have been reported in this last Q. Do you have a source or are you just adding 6mos to the plan on speculation?

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals